Elevance Health (ELV) FY26 Adj. EPS view maintained at 25.50 (exp. 26.05); announced management changes designed to simplify decision-making and strengthen execution across Carelon and Health Benefits.
Importance
Level 1
- Mark Kaye, Executive Vice President and Chief Financial Officer, will expand his responsibilities to include oversight of Carelon.
- Felicia Norwood, Executive Vice President and Chief Health Benefits Officer, will assume responsibility for the Company’s consolidated Health Benefits organization.
- Peter D. Haytaian has announced that he will transition from his role as Executive Vice President and President of Carelon effective May 4, 2026, in order to devote more time to family commitments.
#EQUITIES#US SESSION#MANAGED HEALTH CARE#HEALTH CARE PROVIDERS & SERVICES#HEALTH CARE EQUIPMENT & SERVICES (GROUP)#S&P 500 INDEX#ELEVANCE HEALTH INC#ELV#US EQUITIES